Intraventricular clindamycin enhances interstitial brain fluid drainage and the blood–brain barrier after a traumatic brain injury
Authors:
- Landon S. AshbyLALandon S. Ashby
- Megan G. CroweMCMegan G. Crowe
- Daveraj ChakravartyDCDaveraj Chakravarty
- Gabriel FramptonGFGabriel Frampton
- Ayesha B. DasADAyesha B. Das
- David A. HormuthDHDavid A. Hormuth
- Thomas E. YankeelovTYThomas E. Yankeelov
- Linda J. Noble-HaeussleinLNLinda J. Noble-Haeusslein
- Benjamin J. UmlaufBUBenjamin J. Umlauf
Open Access
- 27 October 2026
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (44)
Abstract
Despite advances in the acute clinical management of severe traumatic brain injuries (TBIs), treating injury-derived secondary pathogenesis remains challenging. We demonstrate intracerebroventricular (I.C.V.) administration of clindamycin alleviates TBI secondary pathogenesis in both focal and diffuse murine models of brain injury. I.C.V. administration of clindamycin increased the motility of ependymal cilia, which line the ventricles and spinal canal, by 30 to 60%, which correlated with interstitial brain fluid drainage through the cortex (r > 0.9 Pearson, n = 4 compounds tested). I.C.V. clindamycin treatment post-TBI also restored the blood–brain barrier (BBB), decreased lesion size, and lowered serum levels of glial fibrillary acidic protein by 2.8-fold. Consistent with these data, a novel objective recognition test revealed an improvement in recognition memory in brain-injured mice treated with clindamycin. These collective findings reveal a counterintuitive finding that I.C.V. clindamycin enhances drainage of toxins from the brain while simultaneously restoring the BBB, potentially providing a new solution for alleviating secondary pathogenesis in brain-injured patients.Keywords
Funding Information
- Mulva Clinic for the Neurosciences (N/A)
- National Cancer Institute (1R01CA260003)
This publication has 80 references indexed in Scilit:
- Prevalence of traumatic brain injury among adults and childrenAnnals of Epidemiology, 2025
- Live-Imaging Centriole Amplification in Mouse Brain Multiciliated Cells2023
- High-Speed Video Microscopy of Ependymal Cilia in Brain Organotypic and Cell Culture Models2023
- A clindamycin acetylated derivative with reduced antibacterial activity inhibits articular hyperalgesia and edema by attenuating neutrophil recruitment, NF-κB activation and tumor necrosis factor-α productionInternational Immunopharmacology, 2023
- The glymphatic system: Current understanding and modelingiScience, 2022
- Tight junction modulation at the blood-brain barrier: Current and future perspectivesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2020
- Dexmedetomidine enhances glymphatic brain delivery of intrathecally administered drugsJournal of Controlled Release, 2019
- Primary blast injury causes cognitive impairments and hippocampal circuit alterationsExperimental Neurology, 2016
- Epidemiology of traumatic brain injury2015
- Anti-inflammatory action of gentamycin through inhibitory effect on neutrophil NADPH oxidase activityComparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 1995